Sign In
to Vote &
Create Storyboards.
 
(University of Colorado Anschutz Medical Campus) Study shows CPT1A may help ovarian cancer cells spread, also resist chemo. Group moves toward clinical trial of CPT1A inhibitor, etomoxir, in chemo-resistant ovarian cancer.
1
0
0


Storyboard
Print
Share this Article



Comment on this Article

Please Sign In to comment

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard